The Asia Pacific Cold And Flu Supplements Market would witness market growth of 12.5% CAGR during the forecast period (2023-2030).
A rise in spending power and population is another factor influencing market expansion. As private and public entities focus their research & development efforts on creating drug delivery systems and effective medications that can be bought at the neighborhood pharmacy, medical supply store, or online, the opportunity for the market to expand is likely to rise.
Supplements can be purchased over the counter and are available without a prescription. These supplements comprise cough suppressants and antihistamines. Colds can be prevented and treated with the help of the herbal supplement echinacea. As an immune system booster, this herb is recommended. Due to its immune-boosting and antioxidant characteristics, elderberry is frequently used to treat the flu. Many patients use garlic to prevent the symptoms of the common cold. Both Panax ginseng and Panax quinquefolium have been investigated for their capacity to cure upper respiratory tract infections, known as a water-soluble vitamin, vitamin C.
A soluble vitamin called zinc is essential for numerous physiological functions. Cold replication virus is prevented by zinc. It has been shown that using zinc supplements can aid in treating and preventing the common cold. The demand for cold and flu supplements has increased significantly because of changing lifestyles and improved access to supplements through both online and physical retailers. Another element fueling this market is consumers' growing awareness of the medical benefits and features of natural medicines.
Asia-Pacific is anticipated to capture a sizable portion of the market due to a growing awareness of patients' health, particularly in Japan, China, and South Korea. Chinese traditional remedies are also becoming increasingly common all over the world as a way to increase immunity. Additionally, middle-class people in developing nations like China and India are spending more on items that are used as a preventative measure against illness, like immunity-boosting vitamins and minerals. Due to this, the market will grow steadily throughout the region in the projection period.
The China market dominated the Asia Pacific Cold And Flu Supplements Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,964.5 million by 2029. The Japan market anticipated to grow at a CAGR of 11.8% during (2023 - 2030). Additionally, The India market would register a CAGR of 13.2% during (2023 - 2030).
Based on Product, the market is segmented into Vitamins & Minerals, Herbal Extracts, and Natural Molecules. Based on Distribution Channel, the market is segmented into Pharmacies & Drug Stores, Hypermarkets & Supermarkets, Online, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Cold And Flu Supplements Market is Projected to reach USD 35.5 Billion by 2030, at a CAGR of 11.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Nordic Naturals, Inc., Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG), Pfizer, Inc., Amway Corporation, NOW Foods, Inc., Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.), Neurobiologix, Inc., Himalaya Global Holdings Ltd., Nu Skin Enterprises, Inc., and Nature’s Sunshine Products, Inc.
By Product
By Distribution Channel
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
